Salzman International

What Salzman International does

Salzman International is a privately held, family-owned wholesaler of animal byproducts founded in 1946 (originally as Centennial Corp.) and headquartered in Davenport, Iowa. The company procures, stores, and distributes porcine, bovine, equine, and ovine tissues and organs—including duodenums, hearts, kidneys, pancreas, pepsin linings, pituitary, spleens, stomachs, thyroid, bull testes, trachea, and concentrated ox bile—for use as raw inputs in pharmaceutical, nutraceutical, and biotech manufacturing. The firm operates with a core staff of approximately seven to ten employees and explicitly serves a global, business-only customer base.

The company's commercial position rests on two regulated assets that materially differentiate it from generic brokers: an APHIS (USDA Animal and Plant Health Inspection Service) listing that qualifies its products for legal export into the European Union, and a dedicated USDA-approved quarantine storage facility that secures inspected inventory for international buyers. These capabilities are reinforced by decades-long procurement relationships with USDA-inspected packers, and by an executive team whose tenure at the firm averages more than two decades (Harry D. Cockrell as CEO since 1974 and partner since 1984; H. Derek Cockrell as President since 1997; Scott Jensen as Quality Director since 1999; Greg Wayt in field representation since 2006; Nick Wayt in production since 2007 and made partner in 2024; Morgan Cullen in operations since 2015).

Salzman International makes money by procuring specified animal tissues from USDA-inspected packers, holding them under controlled-quarantine conditions, and reselling them in defined SKUs to manufacturers globally. Pricing is contract-driven, value-added, and tied to regulatory-grade compliance (EU export eligibility, USDA quarantine custody) rather than commodity spread. Distribution is direct B2B; the company does not sell to individuals. Growth has historically been driven by catalog expansion across species and incremental customer acquisition in regulated pharma and biotech supply chains, with no disclosed funding rounds, acquisitions, or external capital events.

Name

Salzman International

Legal name

Salzman International Inc.

Website

https://salzmanintl.com

Company type

Private

Founded year

1946

Operating status

Operating

Headcount range

1–10 employees

Short description

Salzman International is a family-owned wholesaler of animal byproducts founded in 1946 in Davenport, Iowa, supplying porcine, bovine, equine, and ovine tissues to pharmaceutical, nutraceutical, and biotech manufacturers globally, differentiated by APHIS EU-export listing and a USDA quarantine storage facility.

Ownership category

akta.pro rank

Product category

Animal Byproduct Wholesale

NAICS

Farm Product Raw Material Merchant Wholesalers (4245)

SIC

Wholesale-Farm Product Raw Materials (5150), Wholesale-Miscellaneous Nondurable Goods (5190)

akta.pro primary industry

Byproducts & Rendering Inputs Wholesale (Offal, Hides, Bones, Tallow) (AFAIADAJ)

Keywords

• Animal byproducts wholesale
• Pharmaceutical raw materials
• Nutraceutical ingredients supply
• Glandular materials distribution
• USDA certified animal sourcing

Headquarters

HQ city

Davenport

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Animal By-Product Wholesale: Wholesale distribution of animal by-products (porcine, bovine, equine, ovine) to pharmaceutical, nutraceutical, and biotechnology companies. Revenue generated through product sales, likely transaction-based pricing for bulk orders of glands, organs, and specialized animal materials.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Salzman International is a wholesaler of premium animal byproducts — including porcine, bovine, equine, and ovine glands, organs, and digestive components — supplied exclusively to pharmaceutical, nutraceutical, and biotechnology companies. All materials are sourced from USDA-certified packing facilities, and the Davenport, Iowa facility operates as a USDA quarantine storage facility supporting international trade under APHIS-listed EU compliance.

Product overview

Salzman International is a wholesaler of premium animal byproducts for the pharmaceutical, nutraceutical, and biotechnology industries. The company provides a comprehensive portfolio of porcine, bovine, equine, and ovine byproducts sourced exclusively from USDA-certified packing facilities. Their Davenport, Iowa facility serves as a USDA quarantine storage facility. The product portfolio includes organ glands (pancreas, pituitary, thyroid, adrenal), internal organs (hearts, kidneys, livers, spleens), digestive components (stomachs, duodenums, pepsin linings), and specialized materials (bile, trachea, testis). All products are intended exclusively for pharmaceutical companies, biotech firms, and research organizations.

Differentiator

Problem solved

Functional benefit

Products and services

• Porcine Pancreas Glands

Quantifiable outcome

• Leading supplier of porcine and bovine pancreas glands to insulin manufacturers since the 1970s
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• USDA-Certified Meat Packing FacilitiescoreStrategic or Co-development PartnerLong-standing partnerships with USDA-certified meat packing facilities are central to operations, ensuring exclusive access to high-quality animal by-products with proper documentation and regulatory compliance.
• APHIS (Animal and Plant Health Inspection Service)coreOthersOfficially listed by APHIS to conduct activities in accordance with Regulation (EC) 1069/2009 and Regulation (EU) 142/2011 for international trade in animal-derived materials.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Innovative Research: Innovative Research manufactures and distributes biological specimens, animal-derived reagents, and custom blood products for the diagnostic and research markets. It directly parallels Salzman's wholesale model for animal byproducts sold into pharma-adjacent channels.
• Pel-Freez Biologicals: Pel-Freez Biologicals collects animal tissues, organs, glands, and blood from USDA-inspected slaughterhouses for sale to pharmaceutical, biotech, and diagnostic customers. Like Salzman, it occupies the niche of regulated animal-byproduct wholesale for life-science end markets.
• Rockland Immunochemicals: Rockland produces antibodies and immunological reagents, some derived from animal sources, and sells to pharmaceutical, biotech, and academic customers. While more downstream than Salzman, it operates in the same animal-derived-inputs-for-life-sciences value chain.
• Lampire Biological Laboratories: Lampire supplies animal-derived blood products, plasma, serum, and tissues for use by diagnostics, biotech, and pharmaceutical manufacturers. It is highly comparable to Salzman as a specialized supplier of regulated animal byproducts to life-science buyers.

Broad incumbents

• Darling Ingredients: Darling Ingredients is a global rendering and animal-byproduct processor producing tallow, proteins, and fats for feed, fuel, and specialty uses. While its end markets are broader than Salzman's, it operates in the same upstream animal-byproduct sourcing and processing category.
• Bio-Techne: Bio-Techne (formerly R&D Systems) is a large public life-science tools company that produces proteins, antibodies, and reagents — some animal-derived — for pharma and biotech customers. It overlaps with Salzman's end markets but operates at much greater scale and breadth.
• SARIA Group: SARIA is a European rendering and animal-byproduct company that processes slaughterhouse by-products into fats, proteins, and specialty ingredients. It is comparable to Salzman as a regulated animal-byproduct processor/wholesaler, though operating at much greater scale and breadth.
• Symrise: Symrise is a global manufacturer of flavors, fragrances, and nutritional ingredients, some derived from animal sources (e.g., liver extracts, bile) for food, pet food, and nutraceutical customers. It overlaps with Salzman's animal-derived-ingredients-for-nutraceutical focus but operates as a broad incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/salzmanintl
• LinkedInlinkedin.com/company/salzman-international-inc-

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salzman International